You are here

  • Home
  • Archive
  • Volume 87, Issue Suppl 1
  • O3-S5.03 High-dose valacyclovir decreases plasma HIV-1 levels more than standard dose acyclovir in HIV-1, HSV-2 positive persons: a randomised, crossover trial

Citation Tools

Article menu

Download PDFPDF

Oral Sessions
Clinical sciences oral session 5—treatment: Syphilis, Herpes, &
O3-S5.03 High-dose valacyclovir decreases plasma HIV-1 levels more than standard dose acyclovir in HIV-1, HSV-2 positive persons: a randomised, crossover trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Perti T, Baeten J, Johnston C, et al
O3-S5.03 High-dose valacyclovir decreases plasma HIV-1 levels more than standard dose acyclovir in HIV-1, HSV-2 positive persons: a randomised, crossover trial
Sexually Transmitted Infections 2011;87:A79.